These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17676428)

  • 21. Neuroprotective Effects of Loganin on MPTP-Induced Parkinson's Disease Mice: Neurochemistry, Glial Reaction and Autophagy Studies.
    Xu YD; Cui C; Sun MF; Zhu YL; Chu M; Shi YW; Lin SL; Yang XS; Shen YQ
    J Cell Biochem; 2017 Oct; 118(10):3495-3510. PubMed ID: 28338241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
    Kato H; Kurosaki R; Oki C; Araki T
    Brain Res; 2004 Dec; 1030(1):66-73. PubMed ID: 15567338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manganese does not alter the severe neurotoxicity of MPTP.
    Baek SY; Kim YH; Oh SO; Lee CR; Yoo CI; Lee JH; Lee H; Sim CS; Park J; Kim JW; Yoon CS; Kim Y
    Hum Exp Toxicol; 2007 Mar; 26(3):203-11. PubMed ID: 17439923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroglial responses to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse striatum.
    Francis JW; Von Visger J; Markelonis GJ; Oh TH
    Neurotoxicol Teratol; 1995; 17(1):7-12. PubMed ID: 7535890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of manganese exposure on MPTP neurotoxicities.
    Baek SY; Lee MJ; Jung HS; Kim HJ; Lee CR; Yoo C; Lee JH; Lee H; Yoon CS; Kim YH; Park J; Kim JW; Jeon BS; Kim Y
    Neurotoxicology; 2003 Aug; 24(4-5):657-65. PubMed ID: 12900079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
    J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
    Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
    Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice.
    Costa G; Frau L; Wardas J; Pinna A; Plumitallo A; Morelli M
    Mov Disord; 2013 Dec; 28(14):1957-65. PubMed ID: 24108425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson's disease.
    Martin HL; Santoro M; Mustafa S; Riedel G; Forrester JV; Teismann P
    Glia; 2016 Mar; 64(3):386-95. PubMed ID: 26511587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemokines in the MPTP model of Parkinson's disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration.
    Kalkonde YV; Morgan WW; Sigala J; Maffi SK; Condello C; Kuziel W; Ahuja SS; Ahuja SK
    Brain Res; 2007 Jan; 1128(1):1-11. PubMed ID: 17126305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
    Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T
    Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Damage to neurons and oligodendrocytes in the hippocampal CA1 sector after transient focal ischemia in rats.
    Uchida H; Fujita Y; Matsueda M; Umeda M; Matsuda S; Kato H; Kasahara J; Araki T
    Cell Mol Neurobiol; 2010 Oct; 30(7):1125-34. PubMed ID: 20625811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations of glial cells in the mouse hippocampus during postnatal development.
    Kimoto H; Eto R; Abe M; Kato H; Araki T
    Cell Mol Neurobiol; 2009 Dec; 29(8):1181-9. PubMed ID: 19472050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Near-infrared light treatment reduces astrogliosis in MPTP-treated monkeys.
    El Massri N; Moro C; Torres N; Darlot F; Agay D; Chabrol C; Johnstone DM; Stone J; Benabid AL; Mitrofanis J
    Exp Brain Res; 2016 Nov; 234(11):3225-3232. PubMed ID: 27377070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum.
    Ferger B; Leng A; Mura A; Hengerer B; Feldon J
    J Neurochem; 2004 May; 89(4):822-33. PubMed ID: 15140182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective effect of benzylideneacetophenone derivative on the MPTP model of neurodegeneration in mice.
    Kang JM; Jung JC; Kim H; Lim H; Jang S; Oh S
    Arch Pharm Res; 2008 Sep; 31(9):1098-107. PubMed ID: 18806951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of endurance exercise training on the expression of GFAP, S100B, and NSE in the striatum of chronic/progressive mouse model of Parkinson's disease.
    Al-Jarrah MD; Jamous M
    NeuroRehabilitation; 2011; 28(4):359-63. PubMed ID: 21725169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model.
    Li Y; Liu W; Li L; Hölscher C
    Neuropharmacology; 2016 Feb; 101():255-63. PubMed ID: 26453962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E; Yano R; Yokoyama H; Kato H; Araki T
    Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model.
    Sarkar S; Chigurupati S; Raymick J; Mann D; Bowyer JF; Schmitt T; Beger RD; Hanig JP; Schmued LC; Paule MG
    Neurotoxicology; 2014 Sep; 44():250-62. PubMed ID: 25064079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.